Search companies or stocks...
KLRSKalaris Therapeutics Inc
At close · 02 Sept 2026, 08:00 pm
Disclaimer: This fair value estimate is for informational purposes only and should not be considered as investment advice. Fair value calculations are based on DCF (Discounted Cash Flow), P/E Multiple, and P/S Multiple models and assumptions that may not reflect actual market conditions. Always conduct your own research and consult with a financial advisor before making investment decisions.
Kalaris Therapeutics Inc operates as a pharmaceutical company. The Company specializes in the development of novel cell therapies with a focus on restoring natural immunity…
Current stock price of Kalaris Therapeutics Inc (KLRS) stock is $3.900. The stock price is -0.51% lower in the session. The intraday range can be seen from this page. Volume of Kalaris Therapeutics Inc (KLRS) stock is 16.41K.
Last updated at 02 Sept 2026, 08:00 pm.
The stock price of Kalaris Therapeutics Inc (KLRS) can change with earnings, company news, and overall market sentiment. Kalaris Therapeutics Inc operates in the Healthcare / Biotechnology market, so sector-wide moves can also affect the share price. Use the live price, percentage change, and volume on this page to judge whether a move looks meaningful.
Whether Kalaris Therapeutics Inc looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for KLRS on this page is -1.93. EPS on this page is -2.02. Compare those figures with peers and growth expectations before deciding if the current Kalaris Therapeutics Inc price is justified.
Historical performance for Kalaris Therapeutics Inc (KLRS) is shown on the price chart on this page. Review multi-period moves alongside volume to see how KLRS reacted to past earnings and market events.
Buying Kalaris Therapeutics Inc (KLRS) depends on your risk tolerance, time horizon, and portfolio needs. As a Healthcare name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.
